Bone News and Research

RSS

Gene signature may help develop new therapies against advanced prostate cancer

Researchers have identified a genetic signature in localized prostate cancer that can predict whether the cancer is likely to spread, or metastasize, early in the course of the disease and whether it will respond to anti-androgen therapy, a common treatment for advanced disease.

11 Nov 2020

Study examines the effects of simple measures on the health of active older adults

The DO-HEALTH study led by Zurich-based geriatrician Professor Heike Bischoff-Ferrari has examined the effects of simple measures on the health of healthy adults aged 70 or older.

10 Nov 2020

Researchers identify factors that improve diagnosis of chronic nonbacterial osteomyelitis

Researchers have identified several factors that should help improve the diagnosis of chronic nonbacterial osteomyelitis (CNO), also known as chronic recurrent multifocal osteomyelitis (CRMO).

10 Nov 2020

Japanese woman diagnosed with frosted branch angiitis

Leukemias and lymphomas are life-threatening malignancies affecting white blood cells and the immune system; fortunately, radiotherapy and chemotherapy, combined with stem cell therapy, can improve survival significantly.

10 Nov 2020

Study sheds light on the high burden of late effects among young survivors of acute myeloid leukemia

Adolescent and young adult (AYA) patients treated for acute myeloid leukemia (AML) have a high risk of developing several long-term health complications, a study led by UC Davis Comprehensive Cancer Center researchers has found.

9 Nov 2020

Lateral flow test enables faster, accurate diagnosis of periprosthetic joint infection

The recently FDA-authorized alpha-defensin lateral flow test is a highly accurate, ten-minute test for diagnosis of periprosthetic joint infection (PJI) - a serious and costly complication of total joint replacement, reports a study in The Journal of Bone & Joint Surgery.

9 Nov 2020

White blood cells can be used to attack tumors after completing a special training

Scientists at the National Center for Tumor Diseases Dresden and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program - be utilized for the treatment of tumors.

6 Nov 2020

Study identifies key clinical features of chronic nonbacterial osteomyelitis

New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, identified key clinical features of chronic nonbacterial osteomyelitis (CNO), which leads to an important step toward the development of much-needed classification criteria for a disease that affects children and young adults worldwide.

6 Nov 2020

Oral methotrexate can be an effective intervention for people with knee OA

A new study presented at ACR Convergence, the American College of Rheumatology's annual meeting, shows that after three months of treatment with oral methotrexate, adults with primary knee osteoarthritis (OA) with inflammation had significant improvements in physical function and inflammation, a sign that this inexpensive, generic pill may be an important intervention for knee OA.

6 Nov 2020

Osteoporosis drug increases bone mineral density in the hip and lumbar spine

New research presented at ACR Convergence, the American College Rheumatology's annual meeting, reveals that romosozumab, an osteoporosis drug, produces substantial gains in bone mineral density in the hip and lumbar spine within one year, and that transitioning patients to a potent antiresorptive drug can lead to even more bone density gains.

6 Nov 2020

Anticoagulant drug linked to greater risk of knee and hip replacements in patients with osteoarthritis

New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, shows that use of warfarin, a vitamin K drug widely prescribed to prevent blood clots, is associated with a significantly greater risk of knee and hip replacements in patients with osteoarthritis.

6 Nov 2020

Corticosteroid injections for knee OA do not speed up the progression of disease

REGENHU launches its next generation 3D Bioprinter and software, the R-GEN series and SHAPER, in its mission to revolutionize medicine

REGENHU, a leading global bioprinting company, today announced the launch of the R-GEN platform and SHAPER, a new bioprinter and software designed to cover the entire biofabrication process.

From regenHU Ltd. 4 Nov 2020

Bone News and Research

Gene signature may help develop new therapies against advanced prostate cancer

Study examines the effects of simple measures on the health of active older adults

Researchers identify factors that improve diagnosis of chronic nonbacterial osteomyelitis

Japanese woman diagnosed with frosted branch angiitis

Study sheds light on the high burden of late effects among young survivors of acute myeloid leukemia

Lateral flow test enables faster, accurate diagnosis of periprosthetic joint infection

White blood cells can be used to attack tumors after completing a special training

Study identifies key clinical features of chronic nonbacterial osteomyelitis

Oral methotrexate can be an effective intervention for people with knee OA

Osteoporosis drug increases bone mineral density in the hip and lumbar spine

Anticoagulant drug linked to greater risk of knee and hip replacements in patients with osteoarthritis

Corticosteroid injections for knee OA do not speed up the progression of disease

Older men are underdiagnosed and undertreated for osteoporosis

Commonly prescribed anti-depressant may halt the growth of childhood sarcoma

Study: Blocking energy pathway helps reduce graft-versus-host disease

Report: 800 million children have dangerously high lead levels in blood

Study investigates the ebb and flow of brain ventricles

Study explains the global burden of disability from musculoskeletal conditions

Low dose computed tomography shows potential for opportunistic screening of osteoporosis

REGENHU launches its next generation 3D Bioprinter and software, the R-GEN series and SHAPER, in its mission to revolutionize medicine

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News